Eversept Partners, LP

Q2 2022 13F Holdings Report, Restatement, Options Holdings

Signature - Title
Ron Rosenstraus - Chief Financial Officer
Location
New York, NY
Options holdings as of
June 30, 2022
Notional value $
$383M
Number of holdings
12
Date filed
11/8/2023, 02:37 PM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q1 2022 - Nov 8, 2023
Next filing
Q3 2022 - Nov 8, 2023
Stock holdings
Showing options holdings, see here for stock holdings
Sym Company Class Option Share Change Activity * Price $ Shares Notional Value
Filing 2022 Q2 - Restatement compared to 2022 Q1 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ron Rosenstraus Chief Financial Officer New York, New York 11/8/2023

Eversept Partners, LP ("Eversept") is filing this amendment primarily to correct our previous reporting of put and call option positions. In the Information Table in all reports on Form 13F filed from the fourth quarter of 2017 through the second quarter of 2023, Eversept had erroneously provided the requested information in columns 2-5 of the Information Table with respect to the put and call options themselves, rather than with respect to the securities underlying the options.